Tiran A
Klinisches Institut für Medizinische und Chemische Labordiagnostik, LKH-Universitätsklinikum Graz, Auenbruggerplatz 15, A-8036 Graz.
Wien Med Wochenschr. 2001;151(24):587-9.
An association between Helicobacter pylori infection or cytomegalovirus infection and atherosclerosis has been described. During the last four years, new evidence evolved from a number of studies, which allows to reevaluate the clinical impact of this association. Current knowledge suggests that the association between atherosclerosis and Helicobacter pylori may be accounted for by chance or by confounding from a secondary phenomenon. Regarding cytomegalovirus, a number of animal models and molecular studies propose several different mechanisms, by which the virus may interact with cells of the vessel wall, the immune system or with some of the established risk factors to cause atherosclerosis. Conclusive evidence for the clinical relevance of these experimental findings is still lacking. Some of the uncertainties may be resolved by larger studies, which have started during the last years.
幽门螺杆菌感染或巨细胞病毒感染与动脉粥样硬化之间的关联已被描述。在过去四年中,多项研究产生了新证据,这使得我们能够重新评估这种关联的临床影响。目前的知识表明,动脉粥样硬化与幽门螺杆菌之间的关联可能是偶然的,或者是由继发现象的混杂因素导致的。关于巨细胞病毒,一些动物模型和分子研究提出了几种不同的机制,病毒可能通过这些机制与血管壁细胞、免疫系统或一些既定的危险因素相互作用,从而导致动脉粥样硬化。这些实验结果的临床相关性仍缺乏确凿证据。其中一些不确定性可能会通过近年来启动的更大规模研究得到解决。